Selling a Manufacturing Company to Private Equity (2026): EBITDA Multiples, Named PE Platforms, and the Real Diligence Reality

Selling a manufacturing company to private equity in 2026 is a fundamentally different transaction than selling a service business or a trades rollup target. Manufacturing PE diligence is operationally heavier (equipment appraisals, environmental Phase I, supply chain stress tests, customer concentration deep-dives), the deal structures involve more rollover equity than service deals, and the post-close governance is more invasive (monthly KPI packs, quarterly board meetings, capex approval thresholds, working capital covenants). Owners who run a generic broker auction without understanding the manufacturing PE playbook often miss the highest-multiple buyers entirely.

This guide is for U.S. manufacturing owners running between $1M and $50M of normalized EBITDA. We’ll walk through realistic TEV/EBITDA multiples segmented by EBITDA scale and subsegment, the named PE platforms most active in manufacturing this year (Audax, GenNx360, Trive, Cortec, Wynnchurch, Sterling, Mason Wells, Argosy, GTCR, Onex, Carlyle, KKR, Bain, Genstar), the platform-vs-add-on positioning decision, the manufacturing-specific diligence playbook (capex normalization, environmental Phase I ESA, supply chain documentation, customer contracts, IP audits), the rollover equity mechanics that now appear in 80%+ of deals, and the post-close governance reality.

The framework draws on direct work with 76+ active U.S. lower middle market buyers, including 38 with explicit manufacturing theses. We’re a buy-side partner. The buyers pay us when a deal closes — not you. That includes Audax Industrial Services and adjacent Audax verticals, GenNx360 Capital Partners, Trive Capital, Cortec Group, Wynnchurch Capital, Sterling Group, Mason Wells, Argosy Capital, Industrial Growth Partners, public-company strategic buyers (Watsco WSO, APi Group APG, Comfort Systems FIX, Roper ROP, HEICO HEI, Atkore ATKR), family offices with industrial theses, search funders pursuing precision manufacturing, and strategic regional consolidators. The point isn’t to convince you to sell — it’s to give you an honest read on what selling a manufacturing company to private equity actually looks like in 2026. For a deeper look, see our guide on why pe buying hvac companies. For a deeper look, see our guide on how to sell an hvac business to private equity.

One realistic note before you start. Manufacturing PE multiples have compressed roughly 0.5-1.0x from the 2021 peak as interest rates settled in the 4.5-5.5% range and senior debt for industrial deals widened. Trade press reports from 2021 (“manufacturing trades at 10-12x”) are now structurally inaccurate for sub-$25M EBITDA. The realistic 2026 TEV/EBITDA range you’ll see in the table below reflects what actual deals close at — not what investment bank pitch books show in beauty contests.

“The mistake most manufacturing owners make is anchoring on a public-comps EBITDA multiple from a Roper or HEICO and assuming a sub-$10M EBITDA private business trades the same way. It doesn’t. The right multiple is set by the named LMM PE platforms with active manufacturing mandates — Audax Industrial, Wynnchurch, GenNx360, Cortec, Trive — and what their LP-fund mechanics will support. CT works directly with 38 manufacturing-focused buyers in our 76+ buyer network. The buyers pay us when a deal closes, not you.”

Key Takeaways

• Realistic 2026 TEV/EBITDA for U.S. manufacturing: sub-$3M = 4.5-6.5x; $3M-$10M = 6-8.5x; $10M-$25M = 7.5-10x; $25M-$50M = 8.5-11.5x. Premium subsegments (AS9100 aerospace, ISO 13485 medical, NADCAP) add 1-2.5x.
• Named active manufacturing PE platforms: Audax Private Equity, GenNx360, Trive Capital, Cortec Group, Wynnchurch Capital, Sterling Group, Mason Wells, Argosy Capital, Industrial Growth Partners, GTCR Industrials, Onex Industrials, Carlyle Industrials, KKR Industrials, Bain Capital industrials, Genstar industrials.
• Public strategic buyers: Watsco (NYSE: WSO), APi Group (NYSE: APG), Comfort Systems USA (NYSE: FIX), Roper Technologies (NYSE: ROP), HEICO (NYSE: HEI), Atkore (NYSE: ATKR). Pay strategic premiums (1-2x above PE) when synergies are clear.
• Platform vs add-on: $5M+ EBITDA + professional management = platform candidate (highest multiples, 4-6 month diligence). $1M-$5M EBITDA = add-on candidate (60-120 day close, platform-discounted multiples).
• Rollover equity is standard: 15-30% of seller proceeds rolled into newco; second exit in 3-6 years. Plan for it in tax structure and personal liquidity planning.
• Manufacturing-specific diligence flags: capex intensity above 8% of revenue, single-customer concentration above 25%, inventory turns below 4x, pre-2026 ERP, environmental compliance gaps, ITAR-restricted contracts without proper export licensing.

Why manufacturing is the largest single sector of U.S. lower middle-market PE deployment in 2026

Industrial and manufacturing services account for an outsized share of U.S. lower middle-market PE deal activity for structural reasons that aren’t going away. First, manufacturing businesses generate stable, asset-backed cash flow that supports senior leverage at LBO debt covenants. Second, manufacturing fragmentation in the U.S. (per the National Association of Manufacturers and BLS Manufacturing data, the sector contains approximately 250,000 firms with 90%+ employing fewer than 100 people) creates an inexhaustible add-on pipeline for platform consolidators. Third, secular tailwinds — reshoring, nearshoring from China and Mexico, supply chain resilience capex, and federal industrial policy (CHIPS Act, IRA manufacturing credits) — are pulling institutional capital into the sector at the fastest rate in 20 years.

The named PE platforms with active manufacturing theses in 2026. Audax Private Equity (Boston-based, $19B AUM, with Audax Industrial Services and broader industrial platforms across machining, fabrication, and aftermarket parts) has been one of the most active manufacturing acquirers in the LMM. GenNx360 Capital Partners (New York-based, focused on industrial businesses with $25M-$250M revenue) targets specialty industrial manufacturers. Trive Capital (Dallas-based, $5B AUM, with extensive industrial portfolio in aerospace, defense, and specialty manufacturing) actively acquires platform and add-on manufacturing businesses. Cortec Group (New York-based, $4B AUM, manufacturing and consumer focus) consolidates niche manufacturing categories. Wynnchurch Capital (Chicago-based, $7B AUM, with deep manufacturing roots since 1999) is one of the most active LMM industrial acquirers. For a deeper look, see our guide on maximize your valuation sell to private equity. For a deeper look, see our guide on why private equity is buying home services companies.

Additional named platforms. Sterling Group (Houston-based, $5B AUM, industrial focus across manufacturing, distribution, and industrial services) actively pursues manufacturing platforms. Mason Wells (Milwaukee-based, with explicit manufacturing thesis spanning packaging, food and beverage, and engineered products) is an active Midwest industrial acquirer. Argosy Capital (Wayne, PA-based, with manufacturing portfolio across precision components and specialty industrials) targets sub-$10M EBITDA manufacturing businesses. Industrial Growth Partners (San Francisco-based, founded 1997, exclusively focused on industrial growth equity) has been a continuous manufacturing investor for nearly three decades. Mega-cap funds with industrial verticals include GTCR Industrials, Onex Industrials, Carlyle Industrials, KKR Industrials, Bain Capital industrials, and Genstar industrials — though these funds typically engage at $25M+ EBITDA platform sizes.

Public-company strategic buyers add a different competitive dynamic. Watsco (NYSE: WSO, HVAC distribution and manufacturing) acquires HVAC-adjacent manufacturers. APi Group (NYSE: APG, specialty industrial services) consolidates specialty manufacturing within their service-and-installation platform. Comfort Systems USA (NYSE: FIX) acquires mechanical contractors with internal manufacturing capabilities. Roper Technologies (NYSE: ROP) is a serial acquirer of niche industrial manufacturers with software content. HEICO (NYSE: HEI) consolidates aerospace and defense aftermarket parts manufacturers. Atkore (NYSE: ATKR) acquires electrical infrastructure manufacturers. Public strategic buyers often pay 1-2x above PE multiples when synergies are clear — particularly customer cross-sell, manufacturing footprint optimization, or distribution leverage.

Realistic 2026 TEV/EBITDA multiples for U.S. manufacturing by size and subsegment

The single most common owner mistake when approaching a manufacturing PE sale is anchoring on the wrong multiple. Owners read trade press, attend NAM (National Association of Manufacturers) conferences, see the headline 10-12x EBITDA multiples paid for $200M+ EBITDA platforms by mega-cap funds, and assume their $4M EBITDA precision machining business trades the same way. It doesn’t. The realistic ranges below come from observed 2024-2026 LMM manufacturing transaction data and reflect what actual deals close at.

Sub-$3M EBITDA: 4.5-6.5x TEV/EBITDA typical. At this size, you’re below the floor for most LMM PE platform investments. Buyer pool is dominated by add-on acquirers (existing PE-backed manufacturing platforms looking for tuck-ins), search funders with manufacturing theses, family offices with industrial mandates, and SBA-financed individual buyers. Deals at this size typically include 20-40% seller financing or earnout, modest rollover equity (10-15% if any), and faster diligence (60-120 days). Multiples bend upward when the business has differentiated certifications (AS9100, ISO 13485, NADCAP), sticky customer relationships, or exposure to a specific PE platform’s consolidation thesis.

$3M-$10M EBITDA: 6-8.5x TEV/EBITDA typical. The sweet spot for LMM manufacturing PE platform investments. Buyer pool widens dramatically: Audax Industrial, GenNx360, Trive, Cortec, Wynnchurch, Sterling, Mason Wells, Argosy, IGP all actively evaluate at this size. Diligence lengthens to 4-6 months. Rollover equity expectations rise to 15-25% of seller proceeds. Multiples push toward 8.5x when the business has recurring revenue (aftermarket parts, service contracts), defensible IP (patents, trade secrets, proprietary processes), or platform-eligible scale (multiple facilities, professional management team).

$10M-$25M EBITDA: 7.5-10x TEV/EBITDA typical. Mid-LMM territory where competition between LMM platform funds intensifies. Mega-cap fund interest emerges at the top of this range (GTCR Industrials, Onex, Carlyle Industrials, KKR Industrials at $20M+ EBITDA). Public-company strategic buyers (Watsco, APi Group, HEICO, Roper, Atkore) actively evaluate. Multiples push toward 10x when the business is platform-eligible (5+ year scalability runway, defensible market position, professional management), has differentiated end-market exposure (aerospace, medical device, semiconductor adjacent), or generates strategic synergies for a public-company acquirer.

$25M-$50M EBITDA: 8.5-11.5x TEV/EBITDA typical. Mega-cap fund territory. Bain Capital industrials, KKR, Carlyle, Onex, GTCR, Genstar all engage. Diligence is institutional (90-180 days, $300K-$1M of buyer-side advisor fees). Investment banker-run auctions become standard. Multiples push toward 11.5x when the business has clear platform thesis (5-7 year value creation runway, identified add-on pipeline, scalable management team), defensible IP, and strong end-market tailwinds (aerospace and defense, medical device, semiconductor, electrification).

Premium subsegments add 1-2.5x to the headline ranges above. Precision aerospace and defense (AS9100-certified, ITAR-registered when applicable, sole-source qualifications): premium 1.5-2.5x. Medical device contract manufacturing (FDA-registered, ISO 13485-certified, validated processes for Class II/III devices): premium 1-2x. NADCAP-certified specialty processors (heat treating, plating, non-destructive testing for aerospace): premium 1-2x. Electronics manufacturing services (EMS) for medical, aerospace, defense: premium 0.5-1.5x. Specialty chemicals with proprietary formulations and IP: premium 1-2x. Food and beverage manufacturing with branded products and SQF/BRC certifications: premium 0.5-1.5x.

EBITDA size	Typical TEV/EBITDA	Dominant buyer types	Premium add-ons
Under $3M EBITDA	4.5-6.5x	PE add-ons, search funders, family offices, SBA buyers	+1-2x for AS9100, ISO 13485, NADCAP
$3M-$10M EBITDA	6-8.5x	LMM PE platforms (Audax Industrial, Wynnchurch, Mason Wells, Argosy)	+1-2x for premium certs, recurring revenue
$10M-$25M EBITDA	7.5-10x	Mid-LMM PE (GenNx360, Trive, Cortec) + public strategics (Watsco, APi, HEICO)	+1-2.5x for aerospace, medical, semi
$25M-$50M EBITDA	8.5-11.5x	Mega-cap PE (Bain, KKR, Carlyle, GTCR, Genstar) + public strategics (Roper, Atkore)	+1-2.5x for platform thesis + IP
Public comps (for context)	11-15x	Public strategics, mega-cap PE	Not directly comparable to LMM private deals

Platform vs add-on: the highest-leverage positioning decision for a manufacturing seller

Every manufacturing PE buyer evaluates a target through one of two lenses: platform investment or add-on acquisition. These are structurally different deal types with different multiples, different diligence intensity, different timelines, and different post-close dynamics. The single most important positioning decision a manufacturing seller makes is determining which lens fits the business and marketing accordingly. Mismatched positioning (running a $4M EBITDA business as a platform candidate when it’s really an add-on) wastes 4-6 months of diligence and produces worse final terms.

Platform investment characteristics. PE buyer evaluating the business as a standalone platform, with the intent to install professional governance, build a board, and pursue 5-15 add-on acquisitions over a 4-6 year hold period. Typical platform criteria: $5M+ EBITDA (some funds will go to $3M for the right thesis), professional management depth (CFO, COO, plant managers separate from owner), scalable infrastructure (ERP, quality systems, multi-facility operations preferred), defensible market position. Multiples: top of the range (7-10x for $5-10M EBITDA, 8-11x for $10-25M EBITDA). Diligence: 4-6 months including QofE, environmental Phase I, customer reference calls, supply chain stress test, IT diligence. Rollover equity: 15-30% of seller proceeds standard.

Add-on acquisition characteristics. PE-backed manufacturing platform buying a smaller business as a tuck-in acquisition. Typical add-on criteria: $1-5M EBITDA, customer base or geographic footprint that complements the platform, accretive synergies (manufacturing footprint optimization, cross-sell, technician headcount, specialty capabilities). Multiples: platform-discounted (1-2x below the platform’s blended multiple, typically 4.5-6.5x for sub-$3M EBITDA, 6-7.5x for $3-5M EBITDA). Diligence: faster and lighter (60-120 days), often skipping QofE in favor of internal CFO review. Rollover equity: lighter (10-15% if any). Post-close: integration into existing platform (rebrand, ERP migration, P&L consolidation, often within 12 months).

How to determine which fits your business. If you’re below $3M EBITDA, you’re an add-on candidate. If you’re $3-5M EBITDA, you’re an add-on for some platforms and a small platform for others — depends on management depth and infrastructure. If you’re $5M+ EBITDA with professional management depth, you’re a platform candidate but should still be open to add-on offers from larger platforms (often the highest-multiple bidders). If you’re $10M+ EBITDA with platform-eligible scale, you’re primarily a platform candidate and add-on positioning would discount your value.

Strategic positioning implications. Platform positioning means leading with the standalone-growth thesis, professional management, scalable infrastructure, and defensible market position. Add-on positioning means leading with the synergy thesis, customer overlap with named platforms, geographic footprint complementarity, and integration-readiness. The CIM you produce should be tailored to the positioning — a CIM written for platform buyers reads completely differently than one written for add-on buyers. Sellers running an investment-bank-led auction often produce a generic CIM that hurts both positionings.

Buyer type	Cash at close	Rollover equity	Exclusivity	Best fit for
Strategic acquirer	High (40–60%+)	Low (0–10%)	60–90 days	Sellers who want a clean exit; competitor or upstream consolidator
PE platform	Medium (60–80%)	Medium (15–25%)	60–120 days	Sellers willing to hold rollover for the second sale; bigger deals
PE add-on	Higher (70–85%)	Low–Medium (10–20%)	45–90 days	Sellers folding into existing platform; faster process
Search fund / ETA	Medium (50–70%)	High (20–40%)	90–180 days	Legacy-conscious sellers wanting an owner-operator successor
Independent sponsor	Medium (55–75%)	Medium (15–30%)	60–120 days	Sellers OK with deal-by-deal capital and longer financing closes

The 12-step manufacturing PE diligence process: what actually happens month by month

Manufacturing PE diligence is operationally heavier than service-business diligence and runs 4-6 months for platform deals, 60-120 days for add-on deals. The work spans financial diligence (Quality of Earnings, working capital normalization, capex normalization), commercial diligence (customer concentration, market position, win-rate analysis), operational diligence (equipment appraisal, plant tours, quality system audits), legal diligence (IP audits, contract reviews, ITAR/EAR export compliance), and environmental diligence (Phase I ESA, Phase II if needed, regulatory compliance history). Each work-stream has its own external advisor, its own timeline, and its own potential to surface deal-killers.

Months 1-2: pre-LOI buyer outreach and indications of interest. Build the manufacturing-specific CIM (40-60 pages including capex normalization, customer concentration breakdown, equipment list with appraisals, supply chain documentation, quality certifications, environmental compliance history). Identify the right buyer pool (Audax, GenNx360, Trive, Cortec, Wynnchurch, Sterling, Mason Wells, Argosy, IGP, plus relevant strategics like Watsco, APi, HEICO, Atkore). Sign NDAs with 8-15 serious bidders. Hold management meetings (in-person plant tours required at this size). Receive 3-7 indications of interest with non-binding TEV ranges. Negotiate to a single LOI with the best buyer.

Months 2-3: LOI signed, exclusivity, financial diligence kickoff. LOI typically grants 60-90 days of exclusivity. Buyer engages a Quality of Earnings firm (Plante Moran, BDO, Crowe, Wipfli Manufacturing & Distribution Practice, Eide Bailly, RSM Manufacturing & Distribution, or one of the Big Four for larger deals). QofE work scope: 36 months of monthly P&L, balance sheet, and cash flow tie-out; revenue recognition review; cost-of-goods-sold normalization; working capital normalization; capex normalization (separating maintenance capex from growth capex); EBITDA bridge (book-to-adjusted-EBITDA reconciliation with documented add-backs).

Months 3-4: commercial diligence, customer reference calls, market position assessment. Buyer engages a commercial diligence firm or runs internal commercial work. Customer concentration analysis (top-10 customers, top-25, by revenue and gross margin contribution). Customer reference calls with seller-approved list (typically 8-15 customers). Market position assessment (win-rate analysis, competitor mapping, share-of-wallet at top customers). End-market growth thesis validation (semiconductor capex outlook, aerospace OEM build rates, medical device pipeline, etc.). Pricing power assessment (ability to pass through input cost inflation).

Months 3-4 (parallel): operational and equipment diligence. Buyer engages an industrial appraiser (Marshall & Stevens, AccuVal, Hilco Valuation Services, etc.) for equipment appraisal at fair market value (FMV) and orderly liquidation value (OLV). Plant walkthroughs with the operations team (typically 2-4 days on-site). Quality system audit (review of ISO 9001, AS9100, ISO 13485, NADCAP, FDA registration documentation as applicable). Capacity analysis (current utilization, expansion capacity at current footprint, additional shifts feasibility). Capex review (5-year history of maintenance vs growth capex, deferred maintenance backlog, near-term capex requirements).

Months 3-4 (parallel): environmental and regulatory diligence. Buyer engages an environmental consultant (AECOM, Stantec, ERM, Ramboll, Apex, etc.) for Phase I Environmental Site Assessment (ESA) on every owned/leased property. Phase I work scope: historical use review (Sanborn maps, aerial photographs, regulatory database search), site visit, interviews with operators, identification of recognized environmental conditions (RECs). If RECs identified, Phase II ESA follows (soil and groundwater sampling, $25-150K per site). Regulatory compliance history review (EPA, OSHA, state DEP citations and enforcement actions over 5-10 years). For ITAR-registered or EAR-controlled product manufacturers, export compliance audit by a specialized law firm.

Months 4-5: legal diligence, IP audit, contract review. Buyer’s law firm runs full legal diligence: corporate documents, capitalization, prior financing documents, real estate, equipment leases, customer contracts, supplier contracts, employment matters, IP audit (patents, trade secrets with documentation review, trademarks, copyrights, software licensing), litigation history, regulatory matters, environmental, tax. IP audits are particularly important for manufacturers — proprietary processes are often the most defensible asset and require careful documentation to convey to a buyer. Trade secret documentation (NDA programs, employee IP assignment agreements, restricted-information policies) is often weak in family-owned manufacturers and gets a discount in valuation if not addressed pre-LOI.

Months 5-6: PSA negotiation, working capital target, indemnification. Buyer’s law firm drafts the Purchase and Sale Agreement (PSA). Negotiation focal points: working capital target (negotiate the target during PSA, with a true-up at close based on actual working capital delivered); indemnification caps and survival periods (typical: 10-15% indemnification cap, 18-24 month survival for general reps, 6-7 years for tax reps, indefinite for fundamental reps); escrow (typical 5-10% of purchase price, 12-18 month release); seller representations and warranties (often supplemented with a R&W insurance policy that runs $100-300K in premium for a $30-50M deal); non-compete (typical 4-5 years, geography varies); rollover equity terms; transition services agreement.

Months 5-6 (parallel): regulatory approvals. HSR Act filing required for transactions exceeding the annual threshold (in 2026: approximately $119M transaction value or higher buyer/seller size). 30-day waiting period after filing, with possible second-request investigations on industry-concentrated deals. Industry-specific regulatory review for aerospace and defense (CFIUS for foreign buyers, ITAR change-of-control for ITAR-registered manufacturers, DCAA cost accounting reviews for cost-plus government contractors), medical device (FDA notification of change-of-control), food (FDA registration update). State regulatory updates as applicable (workers comp, unemployment insurance, sales tax registrations, state professional licenses).

Month 6: close. Working capital adjustment finalized (target vs actual at close, true-up paid at close). Escrow funded. Purchase price wired (less escrow, less rollover equity, less seller note if any). Equity rollover documented (seller signs subscription agreement for newco common units). Employment agreements executed (buyer often requires founder employment agreement for 12-36 month transition period). Real estate closing (if owned, often held in seller’s real estate entity and leased back to newco at market rate). Customer notification per contractual requirements. Press release (if buyer is public or chooses to disclose).

Manufacturing-specific Quality of Earnings (QofE): the capex and inventory adjustments that drive valuation

Manufacturing QofE is the most operationally complex of any LMM diligence work-stream. Service businesses have relatively simple QofE (revenue recognition is mostly point-in-time billing, working capital is mostly receivables and payables, capex is light). Manufacturing QofE has to disentangle inventory accounting (FIFO vs LIFO, work-in-progress capitalization, obsolete inventory write-downs), capex normalization (maintenance capex vs growth capex, deferred maintenance, equipment lease vs purchase decisions), revenue recognition (especially for long-cycle manufacturing where percentage-of-completion may apply), and standard cost variance accounting. The CPA firms that specialize in manufacturing QofE include Plante Moran, BDO Manufacturing & Distribution, Crowe Manufacturing & Distribution Services, Wipfli Manufacturing, Eide Bailly Manufacturing, and RSM Manufacturing & Distribution.

Capex normalization is the single biggest manufacturing-specific QofE adjustment. PE buyers care about maintenance capex (the spending required to maintain current EBITDA generation capacity) separately from growth capex (spending that expands future capacity). Sellers often blend these in a single capex line, which obscures the true free cash flow conversion of EBITDA. A QofE will separate them: maintenance capex is typically 2-4% of revenue for fabrication and machining shops, 3-5% for plastics and rubber processors, 4-7% for chemicals and specialty processes, 5-10% for high-precision aerospace or semiconductor adjacent. Growth capex is broken out separately and credited back in the EBITDA-to-free-cash-flow bridge.

Inventory normalization and obsolescence write-downs. Manufacturing inventory accounting is full of judgment: how aggressive is the obsolete inventory reserve, how is work-in-progress capitalized, are there slow-moving items that should be written down, is the LIFO reserve appropriately disclosed, are inventory turns consistent with industry norms (4-6x is healthy for most LMM manufacturing, <4x signals potential obsolescence or working capital trap)? QofE will pressure-test all of these and propose adjustments. Sellers often see $200K-$2M of EBITDA adjustments from inventory normalization alone.

Working capital target negotiation. Working capital target in manufacturing deals is typically calculated as a 12-month rolling average of net working capital (current assets minus current liabilities, excluding cash and debt-like items). Industry-typical net working capital as a percentage of revenue: 12-18% for fabrication and machining, 15-25% for plastics and rubber, 20-30% for chemicals and specialty processors. Negotiate working capital target during the LOI stage, not at close. A poorly-negotiated working capital target can transfer $500K-$3M of value from seller to buyer at the close adjustment.

DSO and DPO metrics PE buyers underwrite. Days Sales Outstanding (DSO) for manufacturing typically runs 35-50 days. Above 60 days signals customer concentration risk or weak collections. Days Payable Outstanding (DPO) typically runs 30-45 days. Below 25 days suggests the seller is overpaying suppliers or missing trade discounts. Inventory turns of 4-6x is healthy; below 4x signals obsolescence. Cash conversion cycle (DSO + DIO − DPO) of 60-90 days is typical for healthy LMM manufacturing. Outliers in any of these metrics get probed in QofE and can result in EBITDA or working capital adjustments.

Equipment appraisal, environmental Phase I ESA, and operational diligence

Manufacturing operational diligence work-streams typically run in parallel with QofE during months 3-4 of the diligence process. The work spans equipment appraisal (industrial appraisers like Marshall & Stevens, AccuVal, Hilco Valuation Services, Tiger Group), environmental Phase I ESA (AECOM, Stantec, ERM, Ramboll), quality system audits (third-party auditors or buyer’s internal QA team), and capacity assessments. Each work-stream has the potential to surface a deal-killer or to materially adjust valuation.

Equipment appraisal mechanics. Industrial appraiser visits each facility, photographs and documents major equipment, and produces an appraisal at three valuation standards: Fair Market Value in Continued Use (FMV-CU, the value of equipment as part of an operating business), Orderly Liquidation Value (OLV, the value if sold over 60-180 days), and Forced Liquidation Value (FLV, the value at auction in 30-60 days). PE lenders typically lend against OLV. The OLV-to-purchase-price ratio matters for buyer financing — a deal where OLV is 35%+ of purchase price has different debt capacity than one where OLV is 10%.

Environmental Phase I ESA scope and findings. Phase I ESA conforms to ASTM E1527-21 standard. Scope: historical use review (Sanborn maps, aerial photographs, regulatory databases), site reconnaissance, interviews with operators, identification of recognized environmental conditions (RECs). Manufacturing-specific Phase I findings: solvent storage and historical use, plating or chemical processing operations, underground storage tanks, off-site contamination migration risk, asbestos in older buildings (pre-1980 construction), lead paint, PCB transformers. RECs identified in Phase I trigger Phase II ESA (soil and groundwater sampling, $25-150K per site).

Phase II findings and remediation negotiation. If Phase II identifies contamination, the deal doesn’t necessarily collapse — but the negotiation gets complex. Options include: seller funds remediation pre-close (slows deal 6-18 months), seller establishes environmental escrow at close (typical 1.5-2x estimated remediation cost for 10-20 years), buyer accepts the environmental risk in exchange for purchase price reduction, or environmental insurance (Pollution Legal Liability or Cleanup Cost Cap policies, $50-200K premium for $5-20M of coverage). The right structure depends on the magnitude of contamination, the remediation timeline, and the buyer’s risk appetite.

Quality system audits for certified manufacturers. Buyers pay premium multiples for AS9100 (aerospace), ISO 9001 (general manufacturing), ISO 13485 (medical device), NADCAP (specialty processes for aerospace), FDA registration (medical device, food, pharmaceutical), ITAR registration (defense). Diligence verifies the certification is current, no major non-conformances in recent audits, and the certification will survive a change of control. ITAR registration in particular has change-of-control reporting requirements (notification to DDTC within 60 days) and CFIUS implications for foreign buyers. Foreign buyers often cannot acquire ITAR-registered manufacturers without divesting the ITAR-controlled operations or obtaining a CFIUS clearance.

Customer concentration, end-market exposure, and the manufacturing commercial diligence playbook

Customer concentration is the single most discount-driving commercial diligence finding in manufacturing PE deals. Manufacturing buyers underwrite customer concentration with two metrics: top-1 customer percentage (revenue, gross margin) and top-10 customer percentage. Common discount thresholds: top-1 customer above 20% triggers concentration discussion; above 30% triggers earnout structure; above 40% often kills institutional PE interest entirely (the deal becomes an SBA-financed individual buyer market). The discount math: a manufacturing business with 35% single-customer concentration typically trades 1-1.5x EBITDA below the comparable business with diversified customer base.

Customer reference calls and tenure analysis. Buyer requests 8-15 customer reference calls during diligence. Sellers typically prepare a list of friendly customers (long-tenured, no recent service issues). Buyer’s commercial diligence firm (or internal team) runs structured reference calls covering: tenure of relationship, share of customer’s spend captured, switching costs and barriers, pricing dynamics (last 3 years of price increases), product or service quality assessment, willingness to continue under new ownership. Customers who reveal weak relationships, pricing pressure, or active sourcing of alternatives can re-price the deal.

End-market exposure assessment. Manufacturing PE buyers underwrite the end-market growth thesis as much as the company itself. Aerospace and defense (commercial OEM build rates per Boeing 737/787 backlogs and Airbus A320/A350; defense spending per DoD budget): structural premium for sole-source qualifications. Medical device (FDA approval pipeline for OEM customers, demographic tailwinds, surgical procedure growth): structural premium for ISO 13485-certified contract manufacturers. Semiconductor adjacent (Applied Materials, Lam Research, KLA capex cycles, fab buildout schedules): cyclical but with current strong tailwind from CHIPS Act. Industrial automation, robotics, EV manufacturing, energy infrastructure: secular growth premiums. Heavy truck, agricultural equipment, traditional energy: cyclical headwinds in 2026.

Pricing power assessment. PE buyers will not pay premium multiples for businesses without demonstrated pricing power. Pricing power in manufacturing is shown through: history of successful price increases (3 years of 3-7% annual price actions held without significant volume loss), input cost pass-through (steel, aluminum, copper, resin, energy cost increases passed to customers within 60-90 days), specification or engineering capabilities that create switching costs, certifications or qualifications that create supplier-of-record status. Manufacturers that absorbed 2021-2023 input cost inflation without passing to customers signal weak pricing power and often see 0.5-1.5x EBITDA discount.

Win-rate and pipeline analysis. PE buyers want to see a quoting and win-rate pipeline that supports the growth thesis. Healthy LMM manufacturing win rates: 25-40% for repeat customers, 10-20% for new customers. Pipeline coverage (active quotes outstanding as multiple of monthly bookings) of 3-6x is healthy. Sellers who can’t produce quoting and win-rate data signal weak commercial discipline and attract conservative valuations. Sellers with strong CRM and quoting analytics (Salesforce, Microsoft Dynamics, ProShop, JobBOSS, ECi, Global Shop) producing clean data attract premium valuations.

Rollover equity, seller financing, and earnouts in manufacturing PE deals

Rollover equity has become a near-universal feature of manufacturing PE deals at $5M+ EBITDA. Rollover equity is the portion of seller proceeds that converts into equity in the post-close newco rather than cash at close. Typical rollover percentages: 15-30% of seller proceeds for platform deals, 10-20% for add-on deals. The rollover gets a second exit in 3-6 years when the PE platform exits to a larger fund or strategic. Properly structured rollover often produces 1.5-3x the rollover value at second exit — meaningful incremental wealth creation for sellers who roll. Underperforming platforms can produce zero return on rollover (or negative if the deal is structured as participating preferred for the PE fund).

How rollover equity is structured. Three common structures: (1) common equity rollover — seller rolls into the same security class as the PE fund, takes proportional risk and return, simplest tax treatment. (2) Preferred-and-common rollover — seller rolls into newco common alongside PE fund preferred (8% PIK + participating), more upside if platform performs but more downside if it doesn’t (preferred gets paid first). (3) Common-with-vesting rollover — seller’s rolled equity vests over 3-4 years tied to continued employment as CEO or chairman, used when buyer wants strong founder retention. Tax treatment: rollover into a partnership (LLC) is usually tax-free under IRC Section 721; rollover into a C-corp via Section 351 also tax-free if structured properly; rollover into S-corp triggers tax.

Seller financing in manufacturing PE deals. Less common than service-business deals but still appears in roughly 30-40% of manufacturing PE transactions, particularly in the $1-5M EBITDA range. Typical seller note structure: 7-10 year amortization, 6-9% interest, subordinated to the senior debt and mezzanine debt, often with 1-2 year payment-in-kind (PIK) period. Properly structured seller notes can be a tax advantage (installment sale treatment under IRC Section 453 spreads capital gains recognition over the note life), but PIK interest is taxable as ordinary income to the seller. Default risk is moderate (5-15% over the note life) for institutional PE buyers.

Earnouts in manufacturing PE deals. Earnouts are common when there’s a valuation gap that can’t be bridged through standard structure. Typical earnout: 10-20% of purchase price, 18-36 month measurement period, tied to revenue or EBITDA milestones. EBITDA-tied earnouts are problematic in manufacturing PE deals because the buyer controls capex, working capital management, and discretionary spending post-close — all of which affect EBITDA. Revenue-tied earnouts are cleaner. Customer-retention earnouts (tied to retention of named customers) work well when customer concentration is the main valuation gap. Realistic collection rates on manufacturing earnouts: 50-70% — meaningfully lower than revenue-only earnouts in service businesses.

How to negotiate the cash-rollover-earnout mix. The headline TEV is the same regardless of mix, but the seller’s realized economics vary widely. A $50M TEV deal could be: (A) 100% cash with 5-10% escrow and 15% indemnification cap — max liquidity, max tax now; or (B) 75% cash + 20% rollover + 5% earnout — less liquidity, more upside, deferred tax on rollover, performance risk on earnout. Sellers should model out each scenario in after-tax terms and weight by personal liquidity needs, retirement timeline, and conviction in the platform thesis. CT’s buy-side work involves walking sellers through the scenario modeling alongside the buyer’s structuring.

Component	Typical share of price	When you actually receive it	Risk to seller
Cash at close	60–80%	Wire on closing day	Low — this is real money
Earnout	10–20%	Over 18–24 months, performance-based	High — routinely paid out at less than face value
Rollover equity	0–25%	At the next platform sale (typically 4–6 years)	Variable — can multiply or go to zero
Indemnity escrow	5–12%	12–24 months after close (if no claims)	Medium — usually returned, sometimes contested
Working capital peg	+/- 2–7% of price	Adjustment at close or 30-90 days post	High — methodology disputes are common

Post-close governance: what changes the day after close

PE post-close governance is more invasive than founder-owners typically expect. PE platforms install a board of directors (typically 3-5 members: 2-3 PE professionals, 1-2 independent directors with industry experience, the founder-CEO if rolling). Board meetings monthly for the first 6 months, quarterly thereafter. Monthly KPI reporting packs (revenue, EBITDA, working capital, capex, cash, customer concentration, pipeline, headcount, safety incidents). Annual budgeting process with PE involvement. Working capital covenants in the senior debt that limit the founder’s discretion. Capex approval thresholds (typically board approval required for capex over $250-500K).

Founder employment agreements. PE buyers typically require the founder to remain employed in some capacity for 12-36 months post-close to ensure transition continuity. Common structures: founder remains CEO with 24-36 month employment agreement; founder transitions to chairman role within 12 months and helps recruit a new CEO; founder remains in a strategic advisor role with reduced operational responsibility. Compensation structures: continued base salary, modified bonus tied to platform KPIs, additional equity grants in the rollover entity (sometimes called “promote equity” or “sweat equity”).

Add-on acquisition dynamics from the founder’s perspective. If you sold as a platform, the PE fund will pursue 5-15 add-on acquisitions over the hold period. Founders often have meaningful input into add-on selection, integration, and executive recruitment from the add-ons. Founders who actively participate in add-on M&A typically see meaningful incremental rollover equity value. Founders who disengage post-close often see slower platform growth and reduced rollover return at second exit. PE funds often write the founder employment agreement to encourage active engagement (bonus tied to platform EBITDA, additional equity grants on add-on closings).

Reporting cadence and management changes. PE platforms frequently install a CFO within 6-12 months post-close (often replacing a long-tenured controller or part-time CFO). The new CFO upgrades financial reporting, ERP, and KPI tracking. Other common installs: VP Operations or COO if not in place, VP Sales for sales-process discipline, HR Director for compliance and culture management. These hires are PE-driven and not always welcomed by founders — but they’re part of the institutional governance package and are typically non-negotiable. Founders who resist the upgrades create platform friction that hurts second-exit value.

Second exit timing and outcomes. PE funds typically exit platform investments in 3-6 years (slightly longer for the 2020-2022 vintages still working through the COVID and post-COVID period). Exits go to larger PE funds, public-company strategic buyers, or sometimes IPO. Founders who rolled equity participate in the second exit. Realistic outcomes: 1.5-2.5x rollover value for solid platforms, 2.5-4x for strong platforms, 1x or less for underperforming platforms. Sellers who roll meaningful equity and stay engaged through second exit often realize total proceeds (cash at first close + rollover at second exit) of 1.3-1.8x the cash-only equivalent.

Manufacturing-specific deal-killers: capex intensity, ITAR, environmental, IP gaps, and ERP age

Manufacturing PE deals fall apart at higher rates than service deals due to operationally complex deal-killers. The most common manufacturing-specific deal-killers: (1) capex intensity above 8% of revenue (signals weak FCF conversion); (2) deferred maintenance backlog discovered in equipment appraisal ($1M+ of near-term capex needed); (3) Phase I ESA RECs that escalate to Phase II findings; (4) customer concentration that won’t survive change of control; (5) IP documentation gaps that prevent trade secret protection; (6) ITAR / EAR compliance gaps; (7) pre-2026 ERP that can’t support institutional-grade reporting.

Capex intensity as a valuation driver. PE buyers calculate maintenance capex as a percentage of revenue and back into adjusted EBITDA after capex. Industries where capex intensity above 8% triggers caution: heavy fabrication, foundry, casting, large machining, specialty processing. Industries where capex intensity above 5% is acceptable: precision machining, assembly, light fabrication. The fix: separate maintenance capex from growth capex in your reporting, document the maintenance capex run-rate over 5 years, and demonstrate that the equipment fleet is in good condition with no near-term replacement requirements.

Trade secret and IP documentation gaps. Many family-owned manufacturers have valuable proprietary processes that are undocumented. The owner knows them, the senior shop floor team knows them, but there’s no formal documentation, no NDA program, no IP assignment from employees to the company, no restricted-information policy. PE buyers cannot place value on trade secrets that aren’t documented. Pre-LOI fix: implement a trade secret protection program (NDAs with all employees, IP assignment agreements, restricted-information policy, documented processes in a controlled-access system) at least 12 months before sale. Patents (when applicable) provide stronger but more expensive protection ($10-30K per patent, 18-36 month prosecution timeline).

ITAR and EAR (Export Administration Regulations) compliance. Manufacturers with defense or dual-use product exposure face ITAR (controlled by State Department DDTC) or EAR (controlled by Commerce Department BIS) regulations. ITAR registration requires annual renewal, export license for any foreign sales, change-of-control notification to DDTC within 60 days, and CFIUS implications for foreign buyers. EAR-controlled products require Export Control Classification Number (ECCN) determination, license requirements depending on destination and end-use. Pre-LOI: audit your export compliance program, ensure ECCN classifications are current, document export licenses, identify any dual-use items that may have been exported without proper classification. Compliance gaps can kill deals or trigger 6-18 month remediation programs.

ERP age and reporting capability. PE platforms expect institutional-grade financial and operational reporting. ERP systems older than 10 years (legacy on-premises systems, custom-built systems, multiple disconnected systems) often can’t produce the reporting required for monthly KPI packs. Buyers either factor in a $200-500K ERP migration cost (which reduces EBITDA-equivalent valuation) or require the seller to migrate pre-close. Modern ERP options for LMM manufacturers: NetSuite, SAP Business One, Microsoft Dynamics 365 Business Central, Epicor Kinetic, Plex Systems (cloud), IQMS (now Dassault DELMIAworks), Global Shop Solutions, Infor CloudSuite Industrial. ERP migration is a 9-18 month project — if you’re planning a sale in 2-3 years, plan the migration now.

Industry associations, trade publications, and the manufacturing M&A ecosystem sellers should know

Manufacturing M&A intelligence flows through a specific ecosystem of trade associations, publications, and conferences. Sellers who plug into this ecosystem 12-24 months pre-sale build pricing intelligence, identify named buyers, and understand industry-specific dynamics. The major trade associations: NAM (National Association of Manufacturers, the broad U.S. manufacturing trade association), AMT (The Association For Manufacturing Technology, focused on machine tool manufacturers and users), NTMA (National Tooling and Machining Association, focused on precision machining and tool-and-die), PMA (Precision Metalforming Association, focused on stamping and metalforming), and MAPI (Manufacturers Alliance for Productivity and Innovation, a research-and-benchmarking organization).

Subsegment-specific associations. Aerospace and defense: AIA (Aerospace Industries Association), NDIA (National Defense Industrial Association), and AS9100-relevant SAE International. Medical device: AdvaMed (Advanced Medical Technology Association), MDMA (Medical Device Manufacturers Association). Plastics: PLASTICS Industry Association, SPE (Society of Plastics Engineers). Specialty chemicals: ACC (American Chemistry Council), SOCMA (Society of Chemical Manufacturers and Affiliates). Food manufacturing: GMA (Grocery Manufacturers Association, now Consumer Brands Association), IFT (Institute of Food Technologists). Industrial automation: A3 (Association for Advancing Automation).

Trade publications worth tracking. American Machinist, Modern Machine Shop, Production Machining, Forging Magazine, MetalForming Magazine, Plastics Technology, Modern Plastics, Food Engineering, Food Manufacturing, Aviation Week (for aerospace), Defense News, Medical Device and Diagnostic Industry (MD+DI), Automation World, Industry Week, Manufacturing Business Technology, Industrial Distribution. PE deal coverage: PE Hub, Mergermarket, S&P Capital IQ, PitchBook, Axios Pro Rata. M&A advisor coverage: SourceScrub, Sutton Place Strategies.

Manufacturing-specialized CPA firms for QofE and tax structuring. Plante Moran (one of the largest manufacturing-focused practices in the U.S., based in Michigan), BDO Manufacturing & Distribution Practice (Big Four-adjacent global practice), Crowe Manufacturing & Distribution Services (extensive automotive and industrial manufacturing experience), Wipfli Manufacturing & Distribution (Midwest-strong), Eide Bailly Manufacturing (focused on Plains and Mountain West), RSM US Manufacturing & Distribution (national practice), Baker Tilly Manufacturing (national practice), Schenck Process (Midwest manufacturing focus), HBK Manufacturing Services. For LMM deals, these specialty practices typically deliver better diligence than generalist Big Four engagements at lower cost.

Industrial conferences for buyer relationship building. IMTS (International Manufacturing Technology Show, biennial in Chicago, the largest U.S. manufacturing trade show), FABTECH (annual fabricating, welding, finishing show), NPE (Plastics, triennial), AeroDef (aerospace and defense), MD&M (medical device manufacturing). Sellers who attend these conferences 12-24 months pre-sale can identify potential strategic buyers, build relationships with PE platform executives present at industry events, and understand industry dynamics. Many manufacturing PE deals originate from relationships built at these conferences 1-3 years before the sale process begins.

Realistic 24-month preparation roadmap for manufacturing PE sale

Manufacturers who get the best PE outcomes start preparing 18-24 months before going to market. The longer prep window reflects the operational complexity of manufacturing diligence: capex normalization needs 24+ months of clean data, customer contracts take 12+ months to renegotiate, environmental gaps take 18+ months to remediate, IP documentation programs take 12+ months to mature, ERP migrations take 9-18 months. Skipping prep doesn’t accelerate the exit — it produces a worse exit at lower multiples with more re-trades during diligence.

Months 24-18: financial cleanup and capex normalization. Move to monthly closes within 15 days. Reconcile bank to books monthly. Get CPA-prepared (not just bookkeeper-prepared) annual financial statements. Separate maintenance capex from growth capex in your reporting. Document the capex run-rate over 5 years. Clean up obsolete inventory write-downs. Implement standard cost accounting if not in place. Pull customer concentration data monthly. Implement KPI dashboards (revenue, EBITDA, working capital, capex, customer concentration, win rates, pipeline).

Months 18-12: management depth, IP documentation, environmental compliance. Identify gaps in management team (CFO, COO, plant managers, VP Sales, VP Operations). Hire or promote into gaps. Implement IP documentation program (NDAs, IP assignment agreements, restricted-information policy). Document trade secrets in controlled-access system. Audit environmental compliance history (EPA, OSHA, state DEP citations and enforcement actions, regulatory permits, SPCC plans, Title V air permits, RCRA hazardous waste registration). Address any open compliance issues. Conduct preliminary Phase I ESA on owned facilities to identify and remediate any RECs before formal diligence.

Months 12-6: customer relationships, ERP, certifications. Renegotiate top customer contracts to multi-year terms with auto-renewal. Document customer relationship history in CRM with depth-of-relationship narrative for top 25 customers. Diversify customer base if any single customer is above 25% of revenue. Migrate from legacy ERP if reporting capabilities are inadequate (this is the longest pre-sale project at 9-18 months). Maintain or upgrade quality certifications (ISO 9001, AS9100, ISO 13485, NADCAP, FDA registration as applicable). Audit ITAR / EAR compliance if applicable.

Months 6-0: diligence package preparation and buyer outreach. Compile 36 months of monthly P&Ls, balance sheets, cash flow statements. Compile 5-year capex history with maintenance vs growth split. Pull customer concentration data, top-25 customer detail, customer reference list. Pull employee roster with tenure, comp, certifications. Pull equipment list with appraisal-ready detail. Pull facility list with ownership/lease status, environmental history. Pull IP inventory (patents, trademarks, trade secrets, licenses). Pull insurance schedule. Pull litigation history. Pull supplier list with concentration data. Begin buyer outreach 6 months before target close, allowing 4-6 months for diligence and 1 month for close.

When NOT to sell to PE: signals that other buyer types fit better

PE is the right buyer for many manufacturing businesses but not all. Owners should evaluate PE alongside other buyer archetypes: public-company strategic acquirers (often pay 1-2x premium when synergies are clear), competitor strategic acquirers (highest multiples for the right synergy fit), family offices (longer hold periods, less governance overhead), search funders (for sub-$5M EBITDA businesses with strong owner-replaceability), ESOPs (for owners prioritizing employee continuity over price).

When a public strategic buyer fits better than PE. If your business has clear synergies with a named public strategic (Watsco WSO for HVAC adjacency, APi Group APG for specialty industrial services, Comfort Systems FIX for mechanical contracting, Roper ROP for software-enabled industrials, HEICO HEI for aerospace aftermarket, Atkore ATKR for electrical infrastructure), the strategic often pays 1-2x above the PE multiple. Trade-off: less rollover equity opportunity (strategic buyers usually pay all cash), less founder optionality (strategic absorbs the business into their operations), but cleaner exit and higher headline multiple.

When a family office fits better than PE. Family offices invest from permanent capital (no fund-life exit pressure) and often hold investments 8-15 years vs PE’s 4-6 years. Multiples are typically slightly below PE (0.5-1x lower) but governance is lighter (smaller board, less monthly reporting overhead, fewer mandated management changes). For founders who want continued operational involvement without PE intensity, family offices can be a better fit. Active manufacturing-focused family offices: Pritzker Private Capital, BDT Capital Partners, J.M. Family Enterprises, Wittington Investments, plus dozens of private family offices that don’t publicly market.

When an ESOP fits better than PE. Employee Stock Ownership Plans (ESOPs) are partial or complete sales of the company to a trust that holds equity for the benefit of employees. Multiples are typically 0.5-1.5x lower than PE (limited by ERISA fairness opinion constraints) but the exit has tax advantages (Section 1042 deferral for C-corp sellers under specific conditions) and preserves employee continuity. ESOPs work best for businesses with stable cash flow, strong management depth, and a founder who values legacy and employee continuity over maximizing exit price.

When NOT to sell to anyone. If you’re running a healthy manufacturing business, generating strong free cash flow, and don’t need liquidity, you may not need to sell. PE timing is driven by personal liquidity needs, succession gaps, industry consolidation pressure, or capital re-investment thresholds. If none of those apply, continuing to run the business and harvest cash flow may produce better lifetime returns than a one-time sale. Run the math: pre-tax cash flow over the next 10 years, discounted at your hurdle rate, vs after-tax sale proceeds invested in liquid markets at expected returns. The math doesn’t always favor the sale.

Common manufacturing PE sale mistakes (and how to avoid them)

Mistake 1: anchoring on public-company multiples. Roper Technologies trades at 30x EBITDA. HEICO trades at 50x. Watsco at 25x. None of these are relevant comparable for a private $5M EBITDA manufacturing business. Public-company multiples reflect liquidity, scale, growth, and capital structure that LMM private businesses don’t have. Anchor on observed LMM transaction data (the ranges in the multiple table earlier in this article), not public comps.

Mistake 2: hiring an investment bank that doesn’t specialize in manufacturing. Generalist sell-side advisors miss the named PE platform pool, miss the strategic synergy mapping, and run an auction process that generic-prices the business. Manufacturing-specialized boutiques (Brown Gibbons Lang & Company, Houlihan Lokey’s industrials practice, Robert W. Baird’s industrial practice, William Blair, Lincoln International’s industrial practice) deliver materially better outcomes at the $5M+ EBITDA level. For sub-$5M EBITDA, a buy-side partner like CT often delivers better outcomes than a sell-side broker.

Mistake 3: refusing rollover equity reflexively. “I want all cash, not paper.” This is a common founder reflex but often costs $1-5M of after-tax wealth on a $20-50M deal. Rollover equity that compounds at 15-25% IRR over 4-5 years (typical for PE platforms) produces meaningful incremental wealth. The right question isn’t “all cash vs rollover” but “what rollover percentage matches my liquidity needs and conviction in the platform thesis?”

Mistake 4: under-investing in pre-sale ERP and reporting. Founders often run their business on a 15-year-old custom system or a stack of disconnected tools. PE buyers see this as an immediate $200-500K post-close investment cost and discount the EBITDA accordingly. Pre-sale ERP investment of $200-500K typically returns $1-3M in higher offers and prevented re-trades. Plan the migration 18-24 months ahead.

Mistake 5: hiding customer concentration. PE buyers will discover customer concentration in QofE within 30 days. Hiding it in the CIM destroys credibility and triggers a re-trade. Surface it early, frame it (sole-source qualification, switching cost story, multi-year contract), and propose mitigants (earnout structure, customer-retention covenant, founder retention to maintain relationship). Owned and framed concentration is far less damaging than hidden concentration discovered in diligence.

Mistake 6: underpreparing for environmental Phase I. Many manufacturers have decades of historical operations on the same site — some with unknown contamination from prior eras. A surprise REC discovered in Phase I can stall a deal 3-6 months and re-price by $500K-$3M. Pre-LOI: commission your own Phase I ESA, identify any RECs, address them before formal diligence. The $5-15K cost of a pre-emptive Phase I prevents 10x that in deal-friction or re-trades.

Conclusion

Selling a manufacturing company to private equity in 2026 is a real, deep, well-functioning market — just an operationally complex one. Realistic TEV/EBITDA multiples are 4.5-11.5x depending on size and subsegment, with premiums for AS9100 aerospace, ISO 13485 medical, NADCAP specialty processes, and platform-eligible scale. Named PE platforms with active manufacturing theses include Audax Industrial, GenNx360, Trive Capital, Cortec Group, Wynnchurch Capital, Sterling Group, Mason Wells, Argosy Capital, Industrial Growth Partners, plus mega-cap industrial verticals at GTCR, Onex, Carlyle, KKR, Bain, and Genstar. Public strategic buyers (Watsco, APi Group, Comfort Systems USA, Roper, HEICO, Atkore) often pay 1-2x premiums when synergies are clear. Owners who succeed prepare 18-24 months ahead, invest in financial cleanup and capex normalization, build management depth, document IP, address environmental and ITAR/EAR compliance, position correctly between platform and add-on, negotiate rollover equity intelligently, and choose between PE and other buyer archetypes (public strategics, family offices, search funders, ESOPs) based on personal goals rather than reflex. And if you want to talk to someone who already knows the 38 manufacturing-focused buyers in our 76+ buyer network rather than running a generic broker auction, we’re a buy-side partner — the buyers pay us, not you, no contract required. For a deeper look, see our guide on private equity investment how it really works.

Frequently Asked Questions

What EBITDA multiple do PE firms pay for manufacturing companies in 2026?

Realistic 2026 TEV/EBITDA: sub-$3M EBITDA = 4.5-6.5x; $3M-$10M = 6-8.5x; $10M-$25M = 7.5-10x; $25M-$50M = 8.5-11.5x. Premium subsegments (AS9100 aerospace, ISO 13485 medical, NADCAP specialty processes) add 1-2.5x. Discount triggers (capex intensity above 8% of revenue, single-customer concentration above 25%, inventory turns below 4x, pre-2026 ERP) subtract 0.5-2x.

Which PE firms are most active in manufacturing in 2026?

Audax Private Equity (Audax Industrial Services), GenNx360 Capital Partners, Trive Capital, Cortec Group, Wynnchurch Capital, Sterling Group, Mason Wells, Argosy Capital, and Industrial Growth Partners are the most active LMM platforms. At larger sizes ($25M+ EBITDA), GTCR Industrials, Onex, Carlyle Industrials, KKR Industrials, Bain Capital industrials, and Genstar industrials engage. Public strategics include Watsco (NYSE: WSO), APi Group (NYSE: APG), Comfort Systems USA (NYSE: FIX), Roper Technologies (NYSE: ROP), HEICO (NYSE: HEI), and Atkore (NYSE: ATKR).

Should I position as a platform or add-on?

Below $3M EBITDA: add-on. $3-5M EBITDA: depends on management depth and infrastructure. $5M+ EBITDA with professional management: platform candidate. Platform positioning attracts higher multiples (top of range) but longer diligence (4-6 months) and more rollover equity (15-30%). Add-on positioning closes faster (60-120 days) but at platform-discounted multiples (typically 1-2x below).

How much rollover equity should I expect to roll?

Rollover equity is now standard in 80%+ of manufacturing PE deals. Typical: 15-30% of seller proceeds for platform deals, 10-20% for add-ons. The rollover gets a second exit in 3-6 years when the platform exits. Realistic outcomes: 1.5-3x of rollover value at second exit for solid platforms, 1x or less for underperforming ones. Tax-free rollover into LLC newco under IRC Section 721; into C-corp under Section 351.

What’s a Phase I Environmental Site Assessment and why does it matter?

Phase I ESA conforms to ASTM E1527-21. It’s required by virtually all manufacturing PE buyers. Scope: historical use review (Sanborn maps, regulatory databases), site reconnaissance, identification of recognized environmental conditions (RECs). RECs trigger Phase II ESA (soil/groundwater sampling, $25-150K per site). Surprise environmental findings can stall deals 3-6 months and re-price $500K-$3M. Best practice: commission your own Phase I ESA pre-sale to identify and address RECs before formal diligence.

What’s the difference between maintenance capex and growth capex?

Maintenance capex: spending required to maintain current EBITDA generation capacity (equipment replacement, facility upkeep). Growth capex: spending that expands future capacity (new equipment, capacity additions). Industry typical maintenance capex as a percentage of revenue: 2-4% for fabrication and machining, 3-5% for plastics, 4-7% for chemicals, 5-10% for high-precision aerospace or semiconductor. PE buyers calculate adjusted EBITDA after maintenance capex (called “EBITDA − maintenance capex” or sometimes “cash EBITDA”) when underwriting valuation. Sellers who can’t separate the two get penalized.

How long does a manufacturing PE diligence process take?

4-6 months for platform deals, 60-120 days for add-on deals. Months 1-2: outreach, IOIs, LOI. Months 2-3: financial diligence (QofE), commercial diligence kickoff. Months 3-4: operational diligence (equipment appraisal, environmental Phase I ESA, quality system audit). Months 4-5: legal diligence (IP audit, contract review, ITAR/EAR compliance). Months 5-6: PSA negotiation, regulatory approvals (HSR if applicable), close.

What customer concentration kills a PE manufacturing deal?

Top-1 customer above 20% triggers concentration discussion; above 30% triggers earnout structure or customer-retention covenant; above 40% often kills institutional PE interest. The discount math: a manufacturing business with 35% single-customer concentration trades 1-1.5x EBITDA below comparable diversified businesses. Mitigants: long-term contracts (3-5 year with auto-renewal), sole-source qualifications, switching cost story documented, founder retention to maintain relationship through transition.

Do I need to upgrade my ERP before selling?

If your ERP is older than 10 years and can’t produce monthly KPI packs (revenue, EBITDA, working capital, capex, customer concentration, win rates, pipeline), buyers will factor in a $200-500K post-close ERP migration cost and discount EBITDA-equivalent valuation. Modern LMM manufacturing ERP options: NetSuite, SAP Business One, Microsoft Dynamics 365 BC, Epicor Kinetic, Plex Systems, IQMS/DELMIAworks, Global Shop, Infor CloudSuite. Migration is 9-18 months — plan it 18-24 months pre-sale.

What’s ITAR and EAR and why does it matter for my sale?

ITAR (International Traffic in Arms Regulations): controlled by State Department DDTC for defense articles and services. Annual registration required. Change-of-control notification to DDTC within 60 days. CFIUS implications for foreign buyers. EAR (Export Administration Regulations): controlled by Commerce Department BIS for dual-use items. ECCN classification required. Compliance gaps can kill deals or trigger 6-18 month remediation. Pre-LOI: audit export compliance program, document ECCN classifications, identify potential dual-use items.

What manufacturing-specialized CPA firms do PE buyers hire for QofE?

Plante Moran (largest U.S. manufacturing-focused practice), BDO Manufacturing & Distribution Practice, Crowe Manufacturing & Distribution Services, Wipfli Manufacturing & Distribution, Eide Bailly Manufacturing, RSM US Manufacturing & Distribution, Baker Tilly Manufacturing. These specialty practices deliver better diligence than generalist Big Four engagements at lower cost in the LMM. Sellers should pre-emptively engage one of these firms 12-18 months pre-sale for sell-side QofE.

What’s the difference between selling to PE and selling to a public strategic buyer?

PE: typical 4.5-11.5x TEV/EBITDA, 4-6 month diligence, 15-30% rollover equity, founder employment 12-36 months, 4-6 year hold period before second exit. Public strategic (Watsco, APi Group, Comfort Systems USA, Roper, HEICO, Atkore): often pay 1-2x premium when synergies are clear, all-cash deals more common, faster integration into the strategic, no rollover equity, single exit (not a 2-stage PE-to-strategic path). Strategics fit best when there’s clear synergy (customer cross-sell, manufacturing footprint optimization, distribution leverage).

How is CT Acquisitions different from a sell-side investment bank or broker?

We’re a buy-side partner, not a sell-side broker. Sell-side bankers represent you and charge 4-8% of the deal (often $1-4M on a $25-50M manufacturing deal) plus monthly retainers, run a 6-9 month auction, and require 12-month exclusivity. We work directly with 76+ buyers — including 38 with explicit manufacturing theses across machining, fabrication, assembly, specialty chemicals, food, packaging, plastics, aerospace, medical device, industrial automation — who pay us when a deal closes. You pay nothing. No retainer, no exclusivity, no contract until a buyer is at the closing table. We move faster (60-150 days from intro to close) because we already know who the right buyer is rather than running an auction to find one.

Sources & References

All claims and figures in this analysis are sourced from the publicly available references below.

1. U.S. Small Business Administration 7(a) Loan Program — SBA 7(a) loan program mechanics including $5M maximum loan, 10% buyer equity requirement, 10-year amortization for goodwill — relevant to sub-$3M EBITDA manufacturing deals financed by individual buyers.
2. IRS Section 721 Partnership Contributions — IRC Section 721 governs tax-free contributions of property to partnerships, the standard mechanism for manufacturing PE rollover equity into LLC newco structures.
3. National Association of Manufacturers (NAM) — NAM data on U.S. manufacturing fragmentation: approximately 250,000 firms with 90%+ employing fewer than 100 people, supporting the structural add-on pipeline for PE platform consolidators.
4. Association For Manufacturing Technology (AMT) — AMT industry data on U.S. machine tool consumption, manufacturing technology trends, and IMTS conference (largest U.S. manufacturing trade show) supporting buyer relationship-building for sellers.
5. U.S. Bureau of Labor Statistics Manufacturing Sector — BLS Manufacturing data on employment, productivity, and sector composition supporting the manufacturing M&A market structural assessment.
6. U.S. Bureau of Economic Analysis Manufacturing GDP — BEA data on manufacturing’s contribution to U.S. GDP and industrial output trends supporting the secular tailwind thesis for manufacturing PE deployment.
7. Audax Private Equity Industrial Investment Strategy — Public information on Audax Private Equity, a $19B+ AUM Boston-based manufacturer-focused LMM PE firm with active industrial services portfolio across machining, fabrication, and aftermarket parts.
8. Wynnchurch Capital Industrial Portfolio — Public information on Wynnchurch Capital, a $7B+ AUM Chicago-based manufacturing-focused LMM PE firm continuously active in industrial acquisitions since 1999.